Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apollon has created and obtained proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.
Many of these formulations were created using Apollon’s proprietary artificial intelligence techniques and include:
Apollon NAUSEA™
Apollon PAIN™
Apollon SLEEP™
Apollon ANTI-INFLAMMATORY™
Apollon SEIZURES™
Apollon APPETITE™
Apollon CANCER™ (APM™) – High Times Cannabis Cup 1 st Place Winner
This latest bout of UK market activity comes on a momentous day for the main London Stock Exchange where Cellular Goods (LSE: CBX) becomes the first CBD company to debut in its 320-year history. Its stock price was up 300% in early trading
Medical Cannabis Exports
Dr Stephen Barnhill, CEO and Founder of Apollon, told BusinessCann it is excited by the prospects that lie ahead. “This is a big opportunity for us. we will be a public company that can handle THC. It’s very exciting.
“Apollon delivers high-end formulations of disease-specific products that are patient-specific. One of our aims is to secure the clinical data which can help get the world educated on how to use medical cannabis correctly.
“With all of the necessary licences secured in Jamaica Apollon is now looking to the export markets of Europe, UK, North and South America – anywhere where medical cannabis is legal.”
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz
After giving a medical cannabis talk on the Caribbean island in 2015 he was asked by the Jamaican government to establish a legal treatment facility and assimilate clinical data.
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz
350 % ----------- 400 % gap up would be nice....................... LOL
Hi Kenny, difficult to predict. Just looked back at previous placings in 2019. The company raised about ÂŁ1.4m at what would now be 10.00p per shares to fund the Apollon investment. So you will probably have a lot of selling around that price, but if Apollon pull a rabbit out of the hat, the shares could quickly be soaked up.
I have decided to give it another year to see how Apollon develops the business and the take up of their various strategies/plans. Could be a very exciting time.
Did read that UK CBD to be more regulated for quality, a plus point for us........... IMHO.... DYOR
Andrew the CBX share price has dropped by about half since this was written.
The Doc's trademarked and patents may do well, he appears to be well known and trusted in the industry.....
The weekly amount of oil that he talks about could prove very profitable if he can get the orders to supply.
Once floated the company has spoken about news coming thick and fast to date at this stage the news flow via twitter has IMHO been good.
Hoping to see press reports in the next 2 weeks...... Lets see..
Pleased to hear that you are going to give it another year as you we're the largest shareholder out of us all that declared stock holdings on the old AFRI ........... BB
We used to have some good researchers on the old AFRI BB the chap that managed to get into the road cameras outside the AfriAG HQ was first class........
However it is my belief that Dave Lenigas and the rest of the BOD did not want us finding out too much on the news front, the video I found on Youtube about the AfriAG truck at the border post got removed....
DATE
16.03.21
A full spectrum of opportunities for Apollon Formularies
“…Investors will do very well over the next five years if they invest in Apollon…”
https://total-market-solutions.com/2021/03/apollon/
https://uk.news.yahoo.com/cbd-oil-uk-food-standards-agency-novel-food-regulations-130404215.html
Thanks kenny100 for all the useful info i recently came across Apollon Formularies story and its looking like a great oppurtunity. Definitely one to watch
DYOR
dailygrind
Just keeping the camp fire burning m8...........
Should think after the 13 th we may get interest, my posts may save some doing hours of research........
Thanks...............REC